Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate cream plus NB-UVB versus NB-UVB alone in active vitiligo
NL-OMON33795Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of fluticasone propionate in Vitiligo (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Onset of pigment spread, Degree of pigment spread and 2 more. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
fluticasone propionate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NL-OMON33795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33795.